Both in Pharmaceuticals
Harmony Biosciences Holdings vs Xeris Biopharma Holdings
Over the past year HRMY returned +34.7% and XERS returned +12.4%; their daily moves had a correlation of 0.19.
HRMY +34.7% XERS +12.4%Growth of $1, one year, split-adjusted
| Metric | HRMY | XERS |
|---|---|---|
| Price | $35.40 | $10.20 |
| Market cap | $2.06B | $1.86B |
| Today | −1.76% | −6.12% |
| 1 month | −14.0% | +13.9% |
| 6 months | +14.9% | +68.5% |
| Year to date | −5.4% | +29.9% |
| 1 year | +34.7% | +12.4% |
| Revenue growth (YoY) | +30.3% | +28.7% |
| Gross margin | 75.8% | 86.4% |
| Net margin | 28.9% | −33.8% |
| P/E (TTM) | 11.4× | — |
| Price / sales | 2.1× | 5.5× |
| Net cash | $513.8M | -$130.8M |
| Dividend yield | — | — |
| Volatility (60d) | 36.7% | 57.6% |
| Short % of float | 12.1% | 4.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).